SE7706428L - Kveve-heterocykliska foreningar - Google Patents

Kveve-heterocykliska foreningar

Info

Publication number
SE7706428L
SE7706428L SE7706428A SE7706428A SE7706428L SE 7706428 L SE7706428 L SE 7706428L SE 7706428 A SE7706428 A SE 7706428A SE 7706428 A SE7706428 A SE 7706428A SE 7706428 L SE7706428 L SE 7706428L
Authority
SE
Sweden
Prior art keywords
associations
nitrogen heterocyclic
heterocyclic
nitrogen
heterocyclic associations
Prior art date
Application number
SE7706428A
Other languages
English (en)
Other versions
SE446336B (sv
Inventor
A G Caldwell
N Whittaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7706428L publication Critical patent/SE7706428L/sv
Publication of SE446336B publication Critical patent/SE446336B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7706428A 1976-06-03 1977-06-02 Sett att framstella en 1,5-disubstituerad hydantoin, som har inhiberande effekt pa blodplettsaggregation SE446336B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB5034076 1976-12-02
GB1214577 1977-03-23

Publications (2)

Publication Number Publication Date
SE7706428L true SE7706428L (sv) 1977-12-04
SE446336B SE446336B (sv) 1986-09-01

Family

ID=27256793

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7706428A SE446336B (sv) 1976-06-03 1977-06-02 Sett att framstella en 1,5-disubstituerad hydantoin, som har inhiberande effekt pa blodplettsaggregation
SE8203161A SE8203161L (sv) 1976-06-03 1982-05-19 Sett att framstella 1,5-disubstituerade hydantoinanaloger

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8203161A SE8203161L (sv) 1976-06-03 1982-05-19 Sett att framstella 1,5-disubstituerade hydantoinanaloger

Country Status (12)

Country Link
JP (1) JPS52151168A (sv)
CA (1) CA1176261A (sv)
CH (3) CH645631A5 (sv)
DE (1) DE2724948A1 (sv)
DK (1) DK244577A (sv)
ES (5) ES459412A1 (sv)
FI (1) FI71930C (sv)
FR (1) FR2362839A1 (sv)
HU (1) HU183046B (sv)
NL (1) NL7706064A (sv)
NZ (1) NZ184281A (sv)
SE (2) SE446336B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
IE48747B1 (en) * 1977-09-05 1985-05-15 Wellcome Found Hydantoin derivatives
DK543178A (da) * 1977-12-01 1979-06-02 Wellcome Found Thiodydantoinderivater
EP0003410B1 (en) * 1978-01-23 1982-10-06 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (en) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
US4294972A (en) * 1978-06-15 1981-10-13 Beecham Group Limited 1,2-Disubstituted oxo triazolidine
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
IL59065A0 (en) 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
GB2050371A (en) * 1979-05-09 1981-01-07 Wellcome Found Optically active hydantoin derivatives and pharmaceutical formulations containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
CN1582279A (zh) 2001-11-30 2005-02-16 伊莱利利公司 过氧化物酶体激活的受体激动剂
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
JP2006527189A (ja) * 2003-06-06 2006-11-30 アラーガン、インコーポレイテッド ピペリジニルプロスタグランジンｅ類似体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
FR2362839B1 (sv) 1980-02-01
ES489883A0 (es) 1981-02-16
HU183046B (en) 1984-04-28
ES478156A1 (es) 1979-11-01
JPS6222986B2 (sv) 1987-05-20
ES8103057A1 (es) 1981-02-16
SE446336B (sv) 1986-09-01
FI71930B (fi) 1986-11-28
FI71930C (sv) 1987-03-09
FI771763A (fi) 1977-12-04
NL7706064A (nl) 1977-12-06
FR2362839A1 (fr) 1978-03-24
DK244577A (da) 1977-12-04
CH647511A5 (en) 1985-01-31
NZ184281A (en) 1980-04-28
CH645631A5 (en) 1984-10-15
CA1176261A (en) 1984-10-16
DE2724948A1 (de) 1977-12-15
JPS52151168A (en) 1977-12-15
ES482010A1 (es) 1980-08-16
ES470428A1 (es) 1979-09-01
CH646426A5 (en) 1984-11-30
SE8203161L (sv) 1982-05-19
ES459412A1 (es) 1978-11-01

Similar Documents

Publication Publication Date Title
SE437827B (sv) Herbicidiskt aktiva foreningar
SE7704197L (sv) Pyridinforeningar
SE7701310L (sv) Polyoxygenerade labdanderivat
IT1074158B (it) Cerniera
BE853284A (nl) Scharnier
SE7706428L (sv) Kveve-heterocykliska foreningar
SE7710762L (sv) Farmakologiskt aktiva foreningar
SE424463B (sv) Gangjern
SE7700577L (sv) Oxiegenerade n-aryldiazacykliska foreningar
IT1059278B (it) Cerniera
SE7702771L (sv) Farmakologiskt aktiva foreningar
SE7705792L (sv) Polyamidaminforeningar
SE7707424L (sv) Kemiska foreningar
SE7701722L (sv) Antibakteriella foreningar
SE7704172L (sv) Naftyridinderivat
SE7703736L (sv) Organiska foreningar
FI773303A (fi) Tvaopol innefattande en transistor
SE7614475L (sv) Pyrrolidonforeningar
SE7702106L (sv) Iminoforeningar
SE7713711L (sv) Heterocykliska foreningar
IT1056911B (it) Cerniera
FR2317457A1 (fr) Charniere
IT1084751B (it) Tenuta
IT219851Z2 (it) Cerniera lamp0 c0nfezi0nata
SE7705884L (sv) Bicykliska foreningar